Dr. Reddy’s Laboratories (NYSE:RDY) has launched
Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose
Prefilled Syringe, a therapeutic equivalent generic version of ADAPT
Pharma’s Narcan Injection USP.
The Naloxone Hydrochloride Injection had U.S. sales of ~$31M for the year ended January 2020 according to IQVIA Health.
https://seekingalpha.com/news/3553275-dr-reddys-launches-naloxone-hydrochloride-injection-in-u-s
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.